Published in J Infect Dis on April 07, 2016
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res (2010) 11.42
The genome sequence of herpes simplex virus type 2. J Virol (1998) 3.39
Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis (2003) 3.19
Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J Clin Microbiol (2002) 2.83
New dye-labeled terminators for improved DNA sequencing patterns. Nucleic Acids Res (1997) 2.55
Helicase-primase inhibitor pritelivir for HSV-2 infection. N Engl J Med (2014) 2.36
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev (2003) 1.95
Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem (2014) 1.48
Sequencing multimegabase-template DNA with BigDye terminator chemistry. Genome Res (1998) 1.47
Herpes simplex viruses: mechanisms of DNA replication. Cold Spring Harb Perspect Biol (2012) 1.21
Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2. J Virol (2015) 0.98
Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France. Antiviral Res (2014) 0.89
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus. Drug Resist Updat (2010) 0.89
Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase-primase inhibitor pritelivir. Antiviral Res (2013) 0.86
A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target. J Antimicrob Chemother (2008) 0.86
High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1. Antivir Chem Chemother (2007) 0.84
Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1. J Antimicrob Chemother (2007) 0.84
Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity. Antiviral Res (2008) 0.84
Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations. Antivir Chem Chemother (2008) 0.83
Scientific report: highlights of 25th ICAR, 16-19 April 2012, Sapporo, Japan. Antivir Chem Chemother (2012) 0.78
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial. JAMA (2016) 0.97
Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 promotes Terminase Complex Formation. J Virol (2017) 0.81
Pharmacokinetics and safety of letermovir, a novel anti-human cytomegalovirus drug, in patients with renal impairment. Br J Clin Pharmacol (2017) 0.75
Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects. Clin Pharmacol Drug Dev (2017) 0.75
Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment. Br J Clin Pharmacol (2017) 0.75